PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Positive revenue growth while 1113.HK is negative. John Neff might see a notable competitive edge here.
-100.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-100.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-101.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-101.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.25%
Dividend reduction while 1113.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-309.88%
Negative OCF growth while 1113.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.96%
Negative FCF growth while 1113.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-99.58%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-99.16%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-99.62%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-173.07%
Negative 10Y OCF/share CAGR while 1113.HK stands at 210.79%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-178.15%
Negative 5Y OCF/share CAGR while 1113.HK is at 210.79%. Joel Greenblatt would question the firm’s operational model or cost structure.
-168.71%
Negative 3Y OCF/share CAGR while 1113.HK stands at 210.79%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-105.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-127.49%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-106.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
536.80%
Dividend/share CAGR of 536.80% while 1113.HK is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
988.65%
Dividend/share CAGR of 988.65% while 1113.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
33.80%
3Y dividend/share CAGR of 33.80% while 1113.HK is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.95%
We have a declining book value while 1113.HK shows 9.15%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.